Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment

23 Dec 2020

Abstract excerpt

Background Lipocalin 2 (LCN2), an innate immune protein, plays a pivotal role in promoting sterile inflammation by regulating immune responses. However, the role of LCN2 in diverse cancers remains poorly defined. This research aimed to investigate the correlation between LCN2 expression and immunity and visualize its prognostic landscape in pan-cancer. Methods Raw data in regard to LCN2 expression in cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Kidney Injury Research
Share to S100 Proteins and Annexins
Share to Vitamin C and Antioxidants Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33425761
DOI: 10.3389/fonc.2020.605097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor MicroenvironmentPMID 33425761Read ↗

Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progressionSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

LCN2: Versatile players in breast cancerSemantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarkerSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals that FBXO2 as a potential therapeutic target associated with immune infiltrationSemantic proximity Read ↗

An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-CancerSemantic proximity Read ↗

Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis.Semantic proximity Read ↗

GLN2 as a key biomarker and therapeutic target: evidence from a comprehensive pan-cancer study using molecular, functional, and bioinformatic analysesSemantic proximity Read ↗

Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancerSemantic proximity Read ↗

Increased expression of NXNL1 in breast cancer associated with favorable prognostic and high level of immune infiltration.Semantic proximity Read ↗

LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.